scleroderma
SCLERODERMA
Scleroderma is a connective tissue disorder characterized by skin thickening and fibrosis. It is rare, autoimmune and chronic.
It has an idiopathic cause and not contagious.
Early microvascular damage, mononuclear cell infiltrates and slowly developing fibrosis are the important features of the tissue lesions.
The leading causes of death are pulmonary fibrosis and pulmonary arterial hypertension.

Scleroderma Patient Education

Patient Education

  • An exercise program designed by a physiotherapist is most crucial
    • To reduce contractures and functional impairment
    • To minimize joint deformities
    • To keep the blood freely flowing
  • Rest if joints become inflamed
  • Skin care is very important to keep a good supply of blood flowing to the skin
    • Keep the whole body warm to help open the blood vessels of the skin, especially in the hands and feet
    • Avoid strong detergents or other substances that can irritate the skin
    • Prevent drying of skin
    • Use moisturizers to soften and protect the skin
  • Cosmetic makeup may be used to cover up lesions
    • Inactive lesions with atrophic changes may be managed with injectable cosmetic fillers, injection of autologous fat transplantation or surgical excision
  • Avoid high doses of vitamin C (>1000 mg) as it promotes collagen formation
  • Avoid emotional stress as it reduces blood flow
  • Quit smoking
  • Minimize caffeine intake
  • Avoid sympathomimetic decongestant medications (eg Pseudoephedrine)
  • Avoid high-dose corticosteroid use (>15 mg of Prednisone daily) if possible
  • Check blood pressure regularly to monitor for possible complications
Editor's Recommendations
Most Read Articles
6 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
6 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

3 days ago
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.